Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 82 Pages
Report ld: 4619355
Request Sample
Customized Report
Cardiopulmonary Support System Market Size(US$)

CAGR 2025-2031
2.5%
Market Size,2031
USD 164
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Cardiopulmonary Support System was estimated to be worth US$ 138 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
A cardiopulmonary support system is an integrated set of medical devices and technologies designed to temporarily replace or assist the function of the heart and lungs to ensure that blood is adequately oxygenated and pumped to various organs throughout the body to maintain a patient's vital signs.
North American market for Cardiopulmonary Support System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cardiopulmonary Support System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Cardiopulmonary Support System was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Cardiopulmonary Support System include Johnson & Johnson, Getinge, Abbott, Fresenius Medical Care, Xenios AG, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Support System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cardiopulmonary Support System by region & country, by Type, and by Application.
The Cardiopulmonary Support System market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Support System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiopulmonary Support System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cardiopulmonary Support System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cardiopulmonary Support System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cardiopulmonary Support System Product Introduction
1.2 Global Cardiopulmonary Support System Market Size Forecast
1.2.1 Global Cardiopulmonary Support System Sales Value (2020-2031)
1.2.2 Global Cardiopulmonary Support System Sales Volume (2020-2031)
1.2.3 Global Cardiopulmonary Support System Sales Price (2020-2031)
1.3 Cardiopulmonary Support System Market Trends & Drivers
1.3.1 Cardiopulmonary Support System Industry Trends
1.3.2 Cardiopulmonary Support System Market Drivers & Opportunity
1.3.3 Cardiopulmonary Support System Market Challenges
1.3.4 Cardiopulmonary Support System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cardiopulmonary Support System Players Revenue Ranking (2024)
2.2 Global Cardiopulmonary Support System Revenue by Company (2020-2025)
2.3 Global Cardiopulmonary Support System Players Sales Volume Ranking (2024)
2.4 Global Cardiopulmonary Support System Sales Volume by Company Players (2020-2025)
2.5 Global Cardiopulmonary Support System Average Price by Company (2020-2025)
2.6 Key Manufacturers Cardiopulmonary Support System Manufacturing Base and Headquarters
2.7 Key Manufacturers Cardiopulmonary Support System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cardiopulmonary Support System
2.9 Cardiopulmonary Support System Market Competitive Analysis
2.9.1 Cardiopulmonary Support System Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Cardiopulmonary Support System Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Support System as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Portable
3.1.2 Vertical
3.2 Global Cardiopulmonary Support System Sales Value by Type
3.2.1 Global Cardiopulmonary Support System Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Cardiopulmonary Support System Sales Value, by Type (2020-2031)
3.2.3 Global Cardiopulmonary Support System Sales Value, by Type (%) (2020-2031)
3.3 Global Cardiopulmonary Support System Sales Volume by Type
3.3.1 Global Cardiopulmonary Support System Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Cardiopulmonary Support System Sales Volume, by Type (2020-2031)
3.3.3 Global Cardiopulmonary Support System Sales Volume, by Type (%) (2020-2031)
3.4 Global Cardiopulmonary Support System Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Care Department
4.1.2 Emergency Department
4.1.3 Pediatric Department
4.1.4 Others
4.2 Global Cardiopulmonary Support System Sales Value by Application
4.2.1 Global Cardiopulmonary Support System Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Cardiopulmonary Support System Sales Value, by Application (2020-2031)
4.2.3 Global Cardiopulmonary Support System Sales Value, by Application (%) (2020-2031)
4.3 Global Cardiopulmonary Support System Sales Volume by Application
4.3.1 Global Cardiopulmonary Support System Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Cardiopulmonary Support System Sales Volume, by Application (2020-2031)
4.3.3 Global Cardiopulmonary Support System Sales Volume, by Application (%) (2020-2031)
4.4 Global Cardiopulmonary Support System Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Cardiopulmonary Support System Sales Value by Region
5.1.1 Global Cardiopulmonary Support System Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Cardiopulmonary Support System Sales Value by Region (2020-2025)
5.1.3 Global Cardiopulmonary Support System Sales Value by Region (2026-2031)
5.1.4 Global Cardiopulmonary Support System Sales Value by Region (%), (2020-2031)
5.2 Global Cardiopulmonary Support System Sales Volume by Region
5.2.1 Global Cardiopulmonary Support System Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Cardiopulmonary Support System Sales Volume by Region (2020-2025)
5.2.3 Global Cardiopulmonary Support System Sales Volume by Region (2026-2031)
5.2.4 Global Cardiopulmonary Support System Sales Volume by Region (%), (2020-2031)
5.3 Global Cardiopulmonary Support System Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Cardiopulmonary Support System Sales Value, 2020-2031
5.4.2 North America Cardiopulmonary Support System Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Cardiopulmonary Support System Sales Value, 2020-2031
5.5.2 Europe Cardiopulmonary Support System Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Cardiopulmonary Support System Sales Value, 2020-2031
5.6.2 Asia Pacific Cardiopulmonary Support System Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Cardiopulmonary Support System Sales Value, 2020-2031
5.7.2 South America Cardiopulmonary Support System Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cardiopulmonary Support System Sales Value, 2020-2031
5.8.2 Middle East & Africa Cardiopulmonary Support System Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cardiopulmonary Support System Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Cardiopulmonary Support System Sales Value and Sales Volume
6.2.1 Key Countries/Regions Cardiopulmonary Support System Sales Value, 2020-2031
6.2.2 Key Countries/Regions Cardiopulmonary Support System Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Cardiopulmonary Support System Sales Value, 2020-2031
6.3.2 United States Cardiopulmonary Support System Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Cardiopulmonary Support System Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Cardiopulmonary Support System Sales Value, 2020-2031
6.4.2 Europe Cardiopulmonary Support System Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Cardiopulmonary Support System Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Cardiopulmonary Support System Sales Value, 2020-2031
6.5.2 China Cardiopulmonary Support System Sales Value by Type (%), 2024 VS 2031
6.5.3 China Cardiopulmonary Support System Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Cardiopulmonary Support System Sales Value, 2020-2031
6.6.2 Japan Cardiopulmonary Support System Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Cardiopulmonary Support System Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Cardiopulmonary Support System Sales Value, 2020-2031
6.7.2 South Korea Cardiopulmonary Support System Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Cardiopulmonary Support System Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Cardiopulmonary Support System Sales Value, 2020-2031
6.8.2 Southeast Asia Cardiopulmonary Support System Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Cardiopulmonary Support System Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Cardiopulmonary Support System Sales Value, 2020-2031
6.9.2 India Cardiopulmonary Support System Sales Value by Type (%), 2024 VS 2031
6.9.3 India Cardiopulmonary Support System Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Information
7.1.2 Johnson & Johnson Introduction and Business Overview
7.1.3 Johnson & Johnson Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Johnson & Johnson Cardiopulmonary Support System Product Offerings
7.1.5 Johnson & Johnson Recent Development
7.2 Getinge
7.2.1 Getinge Company Information
7.2.2 Getinge Introduction and Business Overview
7.2.3 Getinge Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Getinge Cardiopulmonary Support System Product Offerings
7.2.5 Getinge Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Abbott Cardiopulmonary Support System Product Offerings
7.3.5 Abbott Recent Development
7.4 Fresenius Medical Care
7.4.1 Fresenius Medical Care Company Information
7.4.2 Fresenius Medical Care Introduction and Business Overview
7.4.3 Fresenius Medical Care Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Fresenius Medical Care Cardiopulmonary Support System Product Offerings
7.4.5 Fresenius Medical Care Recent Development
7.5 Xenios AG
7.5.1 Xenios AG Company Information
7.5.2 Xenios AG Introduction and Business Overview
7.5.3 Xenios AG Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Xenios AG Cardiopulmonary Support System Product Offerings
7.5.5 Xenios AG Recent Development
8 Industry Chain Analysis
8.1 Cardiopulmonary Support System Industrial Chain
8.2 Cardiopulmonary Support System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cardiopulmonary Support System Sales Model
8.5.2 Sales Channel
8.5.3 Cardiopulmonary Support System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Cardiopulmonary Support System market is projected to grow from US$ 141 million in 2025 to US$ 168 million by 2032, at a CAGR of 2.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 121
USD 4900.00
(Single User License)
The global Cardiopulmonary Support System market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 168 million by 2032 with a CAGR of 2.5% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 68
USD 4250.00
(Single User License)
The global market for Cardiopulmonary Support System was estimated to be worth US$ 141 million in 2025 and is projected to reach US$ 168 million, growing at a CAGR of 2.5% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 85
USD 3950.00
(Single User License)
The global Cardiopulmonary Support System market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 2.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 97
USD 2900.00
(Single User License)
The global Cardiopulmonary Support System market size was US$ 138 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 65
USD 4250.00
(Single User License)
The global Cardiopulmonary Support System market is projected to grow from US$ 138 million in 2024 to US$ 164 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 125
USD 4900.00
(Single User License)
The global market for Cardiopulmonary Support System was valued at US$ 138 million in the year 2024 and is projected to reach a revised size of US$ 164 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2025-03-10
Pages: 76
USD 2900.00
(Single User License)
The global Cardiopulmonary Support System revenue was US$ 135 million in 2023 and is forecast to a readjusted size of US$ 160 million by 2030 with a CAGR of 2.5% during the review period (2024-2030).
Published Date: 2024-12-26
Pages: 93
USD 4350.00
(Single User License)
Valued at US$ 138 million in 2024, the global Cardiopulmonary Support System market is forecast to reach US$ 160 million by 2030, at a CAGR of 2.5% during the forecast period.
Published Date: 2024-12-26
Pages: 122
USD 4900.00
(Single User License)
The global market for Cardiopulmonary Support System was valued at US$ 135 million in the year 2023 and is projected to reach a revised size of US$ 160 million by 2030, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2024-12-26
Pages: 74
USD 2900.00
(Single User License)
The global Cardiopulmonary Support System market is projected to grow from US$ 141 million in 2025 to US$ 168 million by 2032, at a CAGR of 2.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 121
The global Cardiopulmonary Support System market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 168 million by 2032 with a CAGR of 2.5% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 68
The global market for Cardiopulmonary Support System was estimated to be worth US$ 141 million in 2025 and is projected to reach US$ 168 million, growing at a CAGR of 2.5% from 2026 to 2032.
Published: 2026-01-19
Pages: 85
The global Cardiopulmonary Support System market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 2.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 97
The global Cardiopulmonary Support System market size was US$ 138 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 65
The global Cardiopulmonary Support System market is projected to grow from US$ 138 million in 2024 to US$ 164 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 125
The global market for Cardiopulmonary Support System was valued at US$ 138 million in the year 2024 and is projected to reach a revised size of US$ 164 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published: 2025-03-10
Pages: 76
The global Cardiopulmonary Support System revenue was US$ 135 million in 2023 and is forecast to a readjusted size of US$ 160 million by 2030 with a CAGR of 2.5% during the review period (2024-2030).
Published: 2024-12-26
Pages: 93
Valued at US$ 138 million in 2024, the global Cardiopulmonary Support System market is forecast to reach US$ 160 million by 2030, at a CAGR of 2.5% during the forecast period.
Published: 2024-12-26
Pages: 122
The global market for Cardiopulmonary Support System was valued at US$ 135 million in the year 2023 and is projected to reach a revised size of US$ 160 million by 2030, growing at a CAGR of 2.5% during the forecast period.
Published: 2024-12-26
Pages: 74
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now